On Tuesday, Pliant Therapeutics Inc (NASDAQ: PLRX) opened higher 1.48% from the last session, before settling in for the closing price of $1.35. Price fluctuations for PLRX have ranged from $1.10 to $16.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -52.88% over the last five years. Company’s average yearly earnings per share was noted 23.34% at the time writing. With a float of $54.10 million, this company’s outstanding shares have now reached $61.39 million.
The firm has a total of 171 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Pliant Therapeutics Inc (PLRX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Pliant Therapeutics Inc is 11.86%, while institutional ownership is 85.31%. The most recent insider transaction that took place on Jan 17 ’25, was worth 587,150. In this transaction President and CEO of this company sold 52,419 shares at a rate of $11.20, taking the stock ownership to the 430,517 shares. Before that another transaction happened on Jan 17 ’25, when Company’s Chief Financial Officer sold 20,148 for $11.20, making the entire transaction worth $225,680. This insider now owns 262,608 shares in total.
Pliant Therapeutics Inc (PLRX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 23.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.07% during the next five years compared to -78.30% drop over the previous five years of trading.
Pliant Therapeutics Inc (NASDAQ: PLRX) Trading Performance Indicators
Check out the current performance indicators for Pliant Therapeutics Inc (PLRX). In the past quarter, the stock posted a quick ratio of 11.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.61, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach -2.22 in one year’s time.
Technical Analysis of Pliant Therapeutics Inc (PLRX)
Analysing the last 5-days average volume posted by the [Pliant Therapeutics Inc, PLRX], we can find that recorded value of 1.36 million was lower than the volume posted last year of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 28.31%. Additionally, its Average True Range was 0.13.
During the past 100 days, Pliant Therapeutics Inc’s (PLRX) raw stochastic average was set at 2.05%, which indicates a significant decrease from 25.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.26% in the past 14 days, which was lower than the 229.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4643, while its 200-day Moving Average is $9.0113. Now, the first resistance to watch is $1.4233. This is followed by the second major resistance level at $1.4765. The third major resistance level sits at $1.5632. If the price goes on to break the first support level at $1.2834, it is likely to go to the next support level at $1.1967. Now, if the price goes above the second support level, the third support stands at $1.1435.
Pliant Therapeutics Inc (NASDAQ: PLRX) Key Stats
There are currently 61,386K shares outstanding in the company with a market cap of 84.10 million. Presently, the company’s annual sales total 0 K according to its annual income of -210,300 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -56,170 K.
